ALLISON REDNER: Open Payments
NPI 1912646100 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,431 in 83 payments from 21 companies in 2025. Trend: 2023 $2,599 · 2024 $1,291 · 2025 $3,431
Food & beverage: $3,074Education: $357
| Company | Payments | Amount |
|---|---|---|
| Lumenis BE inc | 1 | $1,097 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $341 |
| Arcutis Biotherapeutics, Inc. | 8 | $256 |
| Janssen Biotech, Inc. | 7 | $238 |
| Galderma Laboratories, L.P. | 10 | $222 |
| PFIZER INC. | 7 | $203 |
| Regeneron Healthcare Solutions, Inc. | 4 | $186 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $154 |
| Lilly USA, LLC | 5 | $122 |
| Botanix SB Inc | 5 | $87 |
Products named: M22, Zoryve, TREMFYA, DUPIXENT, NEMLUVIO, TALTZ, LITFULO, SOFDRA.
Industry payments across TX — which companies pay providers there.
